![Ian Mortimer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian Mortimer
Vorstandsvorsitzender bei
XENON PHARMACEUTICALS INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
Ian C.
Mortimer is currently President, Chief Executive Officer & Director at Xenon Pharmaceuticals, Inc. since 2025 and President, Treasurer & Director at Xenon Pharmaceuticals USA, Inc. since 2013.
Former roles include Independent Director at Appili Therapeutics, Inc. from 2017 to 2020, Independent Director at Perimeter Medical Imaging AI, Inc. from 2020 to 2025, Director at Perimeter Medical Imaging, Inc., and Chief Financial Officer & Executive Vice President at Arbutus Biopharma Corp.
from 2007 to 2013.
Education includes an MBA from Queen's University and an undergraduate degree from the University of British Columbia.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 07.04.2026 | 34’223 ( 0.04% ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von Ian Mortimer
| Unternehmen | Position | Beginn |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Vorstandsvorsitzender | 03.06.2021 |
Xenon Pharmaceuticals USA, Inc.
 Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Develops clinical-stage biopharmaceutical products | Präsident | - |
Ehemalige bekannte Positionen von Ian Mortimer
| Unternehmen | Position | Ende |
|---|---|---|
| PERIMETER MEDICAL IMAGING AI, INC. | Direktor/Vorstandsmitglied | 29.12.2025 |
| ARBUTUS BIOPHARMA CORPORATION | Finanzdirektor/CFO | 01.10.2013 |
Perimeter Medical Imaging, Inc.
 Perimeter Medical Imaging, Inc. Medical SpecialtiesHealth Technology Provides medical services | Direktor/Vorstandsmitglied | - |
| APPILI THERAPEUTICS INC. | Vorsitzender | - |
Ausbildung von Ian Mortimer
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
43
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perimeter Medical Imaging, Inc.
Perimeter Medical Imaging, Inc. Medical SpecialtiesHealth Technology Provides medical services | Health Technology |
Appili Therapeutics, Inc.
 Appili Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for infectious disease | Health Technology |
Xenon Pharmaceuticals USA, Inc.
Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Develops clinical-stage biopharmaceutical products | Health Technology |
Perimeter Medical Imaging AI, Inc.
 Perimeter Medical Imaging AI, Inc. Medical SpecialtiesHealth Technology Manufactures medical imaging tools | Health Technology |
